Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer
NCT07550205Phase 3Not yet recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- May 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tiaoshen Anti-cancer Granules in ovarian cancer, Insomnia, sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Planned start May 2026; status: not yet recruiting.
02
Drugs
Tiaoshen Anti-cancer Granules
03
Conditions
ovarian cancerInsomnia
Beyond the preview
Go deeper on NCT07550205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550205.